Please login to the form below
4
Revenue 2017Herceptin
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.
Roche appoints Thomas Schinecker as new chief executive officer
caused by cheap biotechnology copies of well-known oncology medicines like Herceptin, Avastin and Rituxan, that once accounted for about 50% of drug sales.
‘Excitement’ around new data for Enhertu
The discovery in the early 1980s that the mutated gene HER-2 could stimulate excessive cell growth and division transformed the treatment of cancer, leading to the development of trastuzumab (Herceptin)
Merck & Co withdraws Keytruda’s US approval in third-line stomach cancer
Keytruda is still approved in combination with Roche’s Herceptin (trastuzumab), fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic HER2-positive
FDA approval for Keytruda/Herceptin combination in first-line advanced gastric cancer
The US Food and Drug Administration (FDA) has approved Merck &Co’s Keytruda plus Roche’s Herceptin and chemotherapy in the first-line setting for HER2-positive advanced gastric or gastroesophageal ... The approval is based on data from the ongoing
Roche reports strong diagnostics sales in Q1 as demand for COVID-19 tests continues
The specific impact of biosimilars on Roche’s MabThera/Rituxan, Avastin and Herceptin franchises remained ‘significant’, particularly in the US.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
